MEDvidi, Inc. vs Pear Therapeutics
MEDvidi, Inc. vs Pear Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: MEDvidi, Inc. is on 54/100 and Pear Therapeutics on 49/100.
Where each one leads
MEDvidi, Inc.
- our overall score: 54/100 against 49/100
- agent readiness: 49/100 against 21/100
Pear Therapeutics
- funding raised: $409M against $2.0M
At a glance
| Measure | MEDvidi, Inc. | Pear Therapeutics |
|---|---|---|
| What it is | An online mental health clinic providing accessible and affordable teleconsultation services for various mental health conditions. | Pioneered prescription digital therapeutics for serious diseases, integrating software with pharmaceuticals. |
| Category | HealthTech, MedTech, Telemedicine, Mental Health Tech | HealthTech, MedTech, Biotech, Digital Therapeutics |
| Sells toBusiness model | B2C | B2B |
| Offering | Platform | Software |
| Founded | 2019 | 2013 |
| Headquarters | San Jose, United States | Boston, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | MEDvidi, Inc. | Pear Therapeutics |
|---|---|---|
| Employees | 185 | Not published |
| Total funding | $2.0M | $409M |
| Latest round | Series A | Post-IPO Equity |
| Valuation | Not published | $1.6B |
| LinkedIn followers | 10,821 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | MEDvidi, Inc. | Pear Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 49/100 |
| Traction | 52/100 | 40/100 |
| Team | 60/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 37/100 | 11/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 58/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | MEDvidi, Inc. | Pear Therapeutics |
|---|---|---|
| Hosting | AWS | Google Cloud |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
MEDvidi, Inc. vs Pear Therapeutics: common questions
Which is better, MEDvidi, Inc. or Pear Therapeutics?
On our 0-100 score MEDvidi, Inc. rates higher (54/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do MEDvidi, Inc. and Pear Therapeutics compare on the numbers?
MEDvidi, Inc. leads on our overall score (54/100 against 49/100), agent readiness (49/100 against 21/100). Pear Therapeutics leads on funding raised ($409M against $2.0M).
Read the full MEDvidi, Inc. review and pricing or the Pear Therapeutics review and pricing. You can also browse other MEDvidi, Inc. alternatives we track.